ALEMBIC PHARMACEUTICALS LTD.
BSE: 533573
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 1.7K+4.7% | 1.6K-8.6% | 1.8K+20.2% | 1.5K+6.3% | 1.4K-11.0% | 1.6K+7.1% | 1.5K |
| Other Income | 25.88+141.2% | 10.73-6.6% | 11.49+47.5% | 7.79-49.6% | 15.46-3.7% | 16.06+410.6% | 3.15 |
| Total Income | 1.7K+5.5% | 1.7K-8.6% | 1.8K+20.4% | 1.5K+5.7% | 1.4K-11.0% | 1.6K+8.0% | 1.5K |
| EXPENSES | |||||||
| Expenditure | 1.5K+5.1% | 1.5K-7.5% | 1.6K+15.6% | 1.4K+4.5% | 1.3K-6.5% | 1.4K+11.4% | 1.3K |
| Tax | -69.61-386.3% | 24.31-34.3% | 36.99+68.1% | 22.00+22.2% | 18.00-47.4% | 34.24-7.5% | 37.01 |
| PROFIT | |||||||
| PBT | 173.46+25.0% | 138.78-35.9% | 216.35+72.4% | 125.52+20.9% | 103.81-48.1% | 200.02-6.2% | 213.20 |
| Net Profit | 243.07+112.3% | 114.47-36.2% | 179.36+73.3% | 103.52+20.6% | 85.81-48.2% | 165.78-5.9% | 176.19 |
| KEY METRICS | |||||||
| OPM % | 14.51%+0.54pp | 13.97%-2.92pp | 16.89%+2.59pp | 14.30%+14.52pp | -0.22%-6.27pp | 6.05%-2.67pp | 8.72% |
| NPM % | 13.93%+7.00pp | 6.93%-2.99pp | 9.92%+3.03pp | 6.89%+0.85pp | 6.04%-4.34pp | 10.38%-1.54pp | 11.92% |
| EPS | 12.37+112.5% | 5.82-36.2% | 9.12+73.1% | 5.27+20.6% | 4.37-48.2% | 8.43-5.9% | 8.96 |
Corporate Events
Board MeetingAPLLTD
20247Nov
Board Meeting
Consider and approve Unaudited Financial Results
BSE Filing ↗ Board MeetingAPLLTD
20245Feb
Board Meeting
Consider and approve Unaudited Financial Results for the qua…
BSE Filing ↗ Board MeetingAPLLTD
20237Nov
Board Meeting
Consider and approve Unaudited Financial Results for the qua…
BSE Filing ↗